Source: Annual Congress 2005 - Treatment of respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
V. A. Kasantsev (St. Petersburg, Russian Federation). The results of bronchoscopy used in the examination and treatment of patients with community acquired pneumonia. Eur Respir J 2005; 26: Suppl. 49, 4060

Member's Comments

No comment yet.

Related content which might interest you: The general evaluation of community acquired pneumonia patients treated in our clinic Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004 The role of flexible fiberoptic bronchoscopy in children with recurrent and persistant pneumonia and the results of the patients in the follow-up Source: Eur Respir J 2006; 28: Suppl. 50, 497s Year: 2006 The general evaluation of elderly patients with community acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004 VRI for the diagnosis of community acquired pneumonia: preliminary results Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008 An audit of microbiological investigations performed on patients admitted with community acquired pneumonia Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 A patient with intractable pneumonia Source: Annual Congress 2006 - Interventional Pulmonology Grand Round: an interactive session Year: 2006 The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005 Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006 Pathological investigations of cardiovascular system in patients who died from community acquired pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 465s Year: 2001 Clinical presentation and evolution of community acquired pneumonia in older patients Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 What is the value of multiple sputum cultures in the routine investigation of community acquired pneumonia (CAP)? Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003 Bronchoscopy findings in COVID-19 patients requiring ECMO-VV Source: Virtual Congress 2021 – Bronchoscopy in the COVID - 19 era: cryobiopsy Year: 2021 Using roncoleukine in basic therapy of patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Comparison of the diagnostic yield of bronchoscopy in the investigation of suspected tuberculosis in patients with and without parenchymal changes Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III Year: 2013 Improving outcome in elderly patients with pneumonia Source: Annual Congress 2005 - Antibiotic therapy: short- and long-term outcomes in LRTI Year: 2005 Communitty acquired pneumonia in very elderly patients: A characteristical approach Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Diagnosis of nosocomial pneumonia in medical ward: repeatability of the protected specimen brush Source: Eur Respir J 2001; 18: 157-163 Year: 2001 A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia Source: Eur Respir J 2001; 18: 362-368 Year: 2001 The clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia of the 3rd group Source: Eur Respir J 2007; 30: Suppl. 51, 548s Year: 2007